A pilot study of all-trans retinoic acid in patients with Philadelphia chromosome-positive chronic myelogenous leukemia

Leukemia

Volumn 11, Issue 7, 1997, Pages 929-932

  Cortes, J ^a   Kantarjian, H ^a,b   O'Brien, S ^a   Beran, M ^a   Estey, E ^a   Keating, M ^a   Talpaz, M ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

All trans retinoic acid; Chronic myeloid leukemia

Indexed keywords

ALPHA INTERFERON; RETINOIC ACID;

ARTICLE; BLAST CELL; BONE MARROW; CANCER STAGING; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; DRY SKIN; HEADACHE; HUMAN; LEUKOCYTE COUNT; NAUSEA; ORAL DRUG ADMINISTRATION; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; XEROSTOMIA;

EID: 0030845501     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400682     Document Type: Article

References (21)

1. Lotan R. Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochem Biophys Acta 1980; 603: 33-91.
2. Sakashita A, Kizaki M, Pakkala S, Schiller G, Tsuruoka N, Tomosaki R, Cameron JF, Dawson MI, Koeffler HP. 9-cis-retinoic acid: effects on normal and leukemic hematopoiesis in vitro. Blood 1993; 81: 1009-1016.
3. Douer D, Koeffler HP. Retinoic acid enhances colony stimulating factor induced clonal growth of normal human myeloid progenitor cells in vitro. Exp Cell Res 1982; 138: 193-198.
4. Gratas C, Menot ML, Dresch C, Chomienne C. Retinoic acid supports granulocytic but not erythroid differentiation of myeloid progenitors in normal bone marrow cells. Leukemia 1993; 7: 1156-1162.
5. + BM cells. Ann Hematol 1993;66: 61-66.
6. Aglietta M, Piacibello W, Sanovio F, Visconti A, Gavosto F. Retinoid acid enhances the growth of only one subpopulation of granulo-monocyte precursors. Acta Hematol 1984; 71: 97-99.
7. Aglietta M, Piacibello W, Stacchini A, Sanavio F, Gavosto F. In vitro effect of retinoic acid on normal and chronic myeloid leukemia granulopoiesis. Leukemia Res 1985; 9: 879-883.
8. Douer D, Koeffler P. Retinoic acid. Inhibition of the clonal growth of human myeloid leukemia cells. J Clin Invest 1982; 69:277-283.
9. Moore MAS, Mertelsmann R, Pelus LM. Phenotypic evaluation of chronic myeloid leukemia. Blood Cells 1981; 7: 217-236.
10. Castleberry RP, Emanuel PD, Zuckerman KS, Cohn S, Strauss L, Byrd RL, Romans A, Chaffee S, Nitschke R, Gualtieri RJ. A pilot study of isotretinoin in the treatment of juvenile chronic myelogenous leukemia. New Engl J Med 1994; 331: 1680-1684.
11. Wiernik PH, Dutcher JP, Paietta E, Hittelman WN, Vyas R, Strack M, Castaigne S, Degos L, Gallagher RE. Treatment of promyelocytic blast of chronic myelogenous leukemia with all-frans retinoic acid. Leukemia 1991; 5: 504-509.
12. Meyskens FL, Kopecky KJ, Appelbaum FR, Balcerzak SP, Samlowski W, Hynes H. Effects of vitamin A on survival in patients with chronic myelogenous leukemia: a SWOG randomized trial. Leukemia Res 1995; 19: 605-612.
13. Cortes J, Talpaz M, Kantarjian H. Chronic myelogenous leukemia: a review. Am J Med 1996; 100: 555-570.
14. Lee JS, Newman RA, Lippman SM, Huber MH, Minor T, Raber MN, Krakoff IH, Hong WK. Phase I evaluation of all-frans retinoic acid in adults with solid tumors. J Clin Oncol 1993; 11: 959-966.
15. Arlin ZA, Mertelsmann R, Berman E, Gee T, Kurland E, Chaganti RSK, Jhanwar SC, Moore MAS, Clarkson BD. 13-cis-retinoic acid does not increase the true remission rate and the duration of true remission (induced by cytotoxic chemotherapy) in patients with chronic phase chronic myelogenous leukemia, J Clin Oncol 1985; 3: 473-176.
16. Cambier N, Wattel E, Menot ML, Guerci A, Chomienne C, Fenaux P. All-frans retinoic acid in adult chronic myelomonocytic leukemia: results of a pilot study. Leukemia 1996; 10: 1164-1167.
17. Gallagher R, Sagayadan G, Dutcher J, Wiernick P. Clonogenic assays support a trial of frans-retinoic acid (tRA) therapy in accelerated phase/early blastic crisis chronic myelogenous leukemia. Biomed Pharmacol 1992; 46: 319.
18. Sagayadan GE, Wiernik PH, Sun N, Ahearn G, Thompson D, Hallam SJ, Hu X-P, Dutcher JP, Gallagher RP. Effect of retinoic acid and Interferon alpha on granulocyte-macrophage colony forming cells in chronic myeloid leukemia: increased inhibition by allfrans and 13-cis-retinoic acids in advanced stage disease. Leukemia Res 1994; 18: 741-748.
19. Muindi J, Frankel SR, Miller WH Jr, Jakubowski A, Scheinberg DA, Young CW, Dmitrovsky E, Warrell RP Jr. Continuous treatment with all-frans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid 'resistance' in patients with acute promyelocytic leukemia. Blood 1992; 79: 299-303.
20. Gallagher RE, Lurie KJ, Leavitt RD, Wiernik PH. Effects of Interferon and retinoic acid on the growth and differentiation of clonogenic leukemic cells from acute myelogenous leukemia patients treated with recombinant leukocyte-αA Interferon. Leukemia Res 1987; 11: 609-619.
21. Zheng A, Savolainen E-R, Koistinen P. All-frans retinoic acid combined with interferon-alpha effectively inhibits granulocyte-macrophage colony formation in chronic myeloid leukemia. Leukemia Res 1996; 20: 243-248.